GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling
暂无分享,去创建一个
Ryan T. Strachan | G. Skiniotis | R. Sunahara | R. Lefkowitz | Alex R. B. Thomsen | T. Cahill | Jeffrey Tarrasch | M. Bouvier | B. Breton | A. Shukla | R. Strachan | Annie M. Dosey | Alem W. Kahsai | B. Pani | F. Heydenreich | Bianca Plouffe | Liyin Huang | Jacob P. Mahoney | A. Thomsen | Biswaranjan Pani
[1] Y. Peterson,et al. The conformational signature of arrestin3 predicts its trafficking and signaling functions , 2016, Nature.
[2] Garth J. Williams,et al. Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser , 2014, Nature.
[3] H. Horiuchi. Seven-transmembrane receptors , 2015 .
[4] G. Skiniotis,et al. 2D Projection Analysis of GPCR Complexes by Negative Stain Electron Microscopy. , 2015, Methods in molecular biology.
[5] Alexander S. Rose,et al. Crystal structure of a common GPCR-binding interface for G protein and arrestin , 2014, Nature Communications.
[6] J. Qian,et al. Visualization of arrestin recruitment by a G Protein-Coupled Receptor , 2014, Nature.
[7] T. Handel,et al. The Chemokine Receptor CCR1 Is Constitutively Active, Which Leads to G Protein-independent, β-Arrestin-mediated Internalization* , 2013, The Journal of Biological Chemistry.
[8] Dennis Brown,et al. Noncanonical Control of Vasopressin Receptor Type 2 Signaling by Retromer and Arrestin* , 2013, The Journal of Biological Chemistry.
[9] A. Kruse,et al. Structure of active β-arrestin1 bound to a G protein-coupled receptor phosphopeptide , 2013, Nature.
[10] Jonathan R. Tomshine,et al. Conformational biosensors reveal GPCR signalling from endosomes , 2013, Nature.
[11] J. Vilardaga,et al. Noncanonical GPCR signaling arising from a PTH receptor–arrestin–Gβγ complex , 2013, Proceedings of the National Academy of Sciences.
[12] M. Millecamps,et al. Differential Association of Receptor-Gβγ Complexes with β-Arrestin2 Determines Recycling Bias and Potential for Tolerance of Delta Opioid Receptor Agonists , 2012, The Journal of Neuroscience.
[13] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[14] T. Gardella,et al. Retromer terminates the generation of cAMP by internalized PTH-receptors , 2011, Nature chemical biology.
[15] Bin Wang,et al. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. , 2009, Nature chemical biology.
[16] M. Lohse,et al. Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors , 2009, PLoS biology.
[17] Cihan Çetin,et al. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. , 2009, Nature chemical biology.
[18] Necmettin Yildirim,et al. β2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics* , 2008, Journal of Biological Chemistry.
[19] S. Marullo,et al. Resonance energy transfer approaches in molecular pharmacology and beyond. , 2007, Trends in pharmacological sciences.
[20] S. Milano,et al. Regulation of receptor trafficking by GRKs and arrestins. , 2007, Annual review of physiology.
[21] Michel Bouvier,et al. Probing the activation-promoted structural rearrangements in preassembled receptor–G protein complexes , 2006, Nature Structural &Molecular Biology.
[22] M. Caron,et al. The Stability of the G Protein-coupled Receptor-β-Arrestin Interaction Determines the Mechanism and Functional Consequence of ERK Activation* , 2003, The Journal of Biological Chemistry.
[23] M. Lohse,et al. Internalization Determinants of the Parathyroid Hormone Receptor Differentially Regulate β-Arrestin/Receptor Association* , 2002, The Journal of Biological Chemistry.
[24] M. Caron,et al. Molecular Determinants Underlying the Formation of Stable Intracellular G Protein-coupled Receptor-β-Arrestin Complexes after Receptor Endocytosis* , 2001, The Journal of Biological Chemistry.
[25] S. Angers,et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. , 2000, The Journal of clinical investigation.
[26] M. Caron,et al. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. , 2000, The Journal of biological chemistry.
[27] M. Caron,et al. Association of β-Arrestin with G Protein-coupled Receptors during Clathrin-mediated Endocytosis Dictates the Profile of Receptor Resensitization* , 1999, The Journal of Biological Chemistry.
[28] Jie Zhang,et al. The β2-adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis , 1999 .
[29] M. Caron,et al. The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] J L Benovic,et al. Agonist-Receptor-Arrestin, an Alternative Ternary Complex with High Agonist Affinity* , 1997, The Journal of Biological Chemistry.
[31] J. Benovic,et al. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.
[32] A. Gilman,et al. G proteins: transducers of receptor-generated signals. , 1987, Annual review of biochemistry.
[33] A. F. Muller,et al. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. , 1986, Molecular pharmacology.
[34] P. Simons,et al. CGP-12177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. , 1983, The Journal of biological chemistry.
[35] S. O'Donnell,et al. Evidence that ICI 118, 551 is a potent, highly Beta 2-selective adrenoceptor antagonist and can be used to characterize Beta-adrenoceptor populations in tissues. , 1980, Life sciences.